Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Stroke. 2009 Oct 15;40(12):3804–3809. doi: 10.1161/STROKEAHA.109.561498

Figure 3.

Figure 3

Unadjusted and adjusted odds of favorable outcome by mRankin (0,1) at 3 months in the loose control group compared to usual care and the tight control group compared to usual care. The null line (0) reflects the usual care group. THIS is the Treatment of Hyperglycemia in Ischemic Stroke Trial and the adjusted analysis for THIS included the subgroup that resembles the THIS Trial patients.